Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: A therapeutic target for colon cancer
2017-01-01 Proto, M. C.; Fiore, D.; Piscopo, C.; Franceschelli, S.; Bizzarro, V.; Laezza, C.; Lauro, G.; Feoli, A.; Tosco, A.; Bifulco, G.; Sbardella, G.; Bifulco, M.; Gazzerro, P.
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells
2016-01-01 Fiore, D.; Proto, M. C.; Pisanti, S.; Picardi, P.; Pagano Zottola, A. C.; Butini, S.; Gemma, S.; Casagni, A.; Laezza, C.; Vitale, M.; Ligresti, A.; Di Marzo, V.; Zisterer, D. M.; Nathwani, S.; Williams, D. C.; Campiani, G.; Gazzerro, P.; Bifulco, M.
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin
2010-01-01 Gazzerro, P.; Malfitano, A. M.; Proto, M. C.; Santoro, A.; Pisanti, S.; Caruso, M. G.; Notarnicola, M.; Messa, C.; Laezza, C.; Misso, G.; Caraglia, M.; Bifulco, M.
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression
2010-01-01 Monteleone, P.; Bifulco, M.; Maina, G.; Tortorella, A.; Gazzerro, P.; Proto, M. C.; Di Filippo, C.; Monteleone, F.; Canestrelli, B.; Buonerba, G.; Bogetto, F.; Maj, M.
Rimonabant kills colon cancer stem cells without inducing toxicity in normal colon organoids
2018-01-01 Fiore, D.; Ramesh, P.; Proto, M. C.; Piscopo, C.; Franceschelli, S.; Anzelmo, S.; Medema, J. P.; Bifulco, M.; Gazzerro, P.
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis
2011-01-01 Pisanti, S.; Picardi, P.; Prota, L.; Proto, M. C.; Laezza, C.; Mcguire, P. G.; Morbidelli, L.; Gazzerro, P.; Ziche, M.; Das, A.; Bifulco, M.
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
2015-01-01 Ciaglia, E.; Torelli, G.; Pisanti, S.; Picardi, P.; D'Alessandro, A.; Laezza, C.; Malfitano, A. M.; Fiore, D.; Pagano Zottola, A. C.; Proto, M. C.; Catapano, G.; Gazzerro, P.; Bifulco, M.
Cannabinoids in the management of spasticity associated with multiple sclerosis
2008-01-01 Malfitano, A. M.; Proto, M. C.; Bifulco, M.
The first cosmetic treatise of history. A female point of view
2008-01-01 Cavallo, P.; Proto, M. C.; Patruno, C.; Sorbo, A. D.; Bifulco, M.
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: Evidence for synergistic effects
2009-01-01 Monteleone, P.; Bifulco, M.; Di Filippo, C.; Gazzerro, P.; Canestrelli, B.; Monteleone, F.; Proto, M. C.; Di Genio, M.; Grimaldi, C.; Maj, M.
Pharmacological actions of statins: A critical appraisal in the management of cancer
2012-01-01 Gazzerro, P.; Proto, M. C.; Gangemi, G.; Malfitano, A. M.; Ciaglia, E.; Pisanti, S.; Santoro, A.; Laezza, C.; Bifulco, M.
Biological and pharmacological roles of N6-isopentenyladenosine: An emerging anticancer drug
2008-01-01 Bifulco, M.; Malfitano, A. M.; Proto, M. C.; Santoro, A.; Caruso, M. G.; Laezza, C.
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
2008-01-01 Esposito, I.; Proto, M. C.; Gazzerro, P.; Laezza, C.; Miele, C.; Alberobello, A. T.; D'Esposito, V.; Beguinot, F.; Formisano, P.; Bifulco, M.
Cannabidiol: State of the art and new challenges for therapeutic applications
2017-01-01 Pisanti, S.; Malfitano, A. M.; Ciaglia, E.; Lamberti, A.; Ranieri, R.; Cuomo, G.; Abate, M.; Faggiana, G.; Proto, M. C.; Fiore, D.; Laezza, C.; Bifulco, M.
Inhibition of 3-hydroxy-3-methylglutarylcoenzyme a reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
2010-01-01 Laezza, C.; Malfitano, A. M.; Proto, M. C.; Esposito, I.; Gazzerro, P.; Formisano, P.; Pisanti, S.; Santoro, A.; Caruso, M. G.; Bifulco, M.
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration
2015-01-01 Pisanti, S.; Picardi, P.; Pallottini, V.; Martini, C.; Petrosino, S.; Proto, M. C.; Vitale, M.; Laezza, C.; Gazzerro, P.; Di Marzo, V.; Bifulco, M.
Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth
2012-01-01 Proto, M. C.; Gazzerro, P.; Di Croce, L.; Santoro, A.; Malfitano, A. M.; Pisanti, S.; Laezza, C.; Bifulco, M.
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
2012-01-01 Laezza, C.; D'Alessandro, A.; Paladino, S.; Malfitano, A. M.; Proto, M. C.; Gazzerro, P.; Pisanti, S.; Santoro, A.; Ciaglia, E.; Bifulco, M.
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux
2018-01-01 Ranieri, R.; Ciaglia, E.; Amodio, G.; Picardi, P.; Proto, M. C.; Gazzerro, P.; Laezza, C.; Remondelli, P.; Bifulco, M.; Pisanti, S.
Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells
2019-01-01 Proto, Maria Chiara; Fiore, Donatella; Forte, Giovanni; Cuozzo, Paola; Ramunno, Anna; Fattorusso, Caterina; Gazzerro, Patrizia; Pascale, Maria; Franceschelli, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: A therapeutic target for colon cancer | 1-gen-2017 | Proto, M. C.; Fiore, D.; Piscopo, C.; Franceschelli, S.; Bizzarro, V.; Laezza, C.; Lauro, G.; Feoli, A.; Tosco, A.; Bifulco, G.; Sbardella, G.; Bifulco, M.; Gazzerro, P. | |
| Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells | 1-gen-2016 | Fiore, D.; Proto, M. C.; Pisanti, S.; Picardi, P.; Pagano Zottola, A. C.; Butini, S.; Gemma, S.; Casagni, A.; Laezza, C.; Vitale, M.; Ligresti, A.; Di Marzo, V.; Zisterer, D. M.; Nathwani, S.; Williams, D. C.; Campiani, G.; Gazzerro, P.; Bifulco, M. | |
| Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin | 1-gen-2010 | Gazzerro, P.; Malfitano, A. M.; Proto, M. C.; Santoro, A.; Pisanti, S.; Caruso, M. G.; Notarnicola, M.; Messa, C.; Laezza, C.; Misso, G.; Caraglia, M.; Bifulco, M. | |
| Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression | 1-gen-2010 | Monteleone, P.; Bifulco, M.; Maina, G.; Tortorella, A.; Gazzerro, P.; Proto, M. C.; Di Filippo, C.; Monteleone, F.; Canestrelli, B.; Buonerba, G.; Bogetto, F.; Maj, M. | |
| Rimonabant kills colon cancer stem cells without inducing toxicity in normal colon organoids | 1-gen-2018 | Fiore, D.; Ramesh, P.; Proto, M. C.; Piscopo, C.; Franceschelli, S.; Anzelmo, S.; Medema, J. P.; Bifulco, M.; Gazzerro, P. | |
| Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis | 1-gen-2011 | Pisanti, S.; Picardi, P.; Prota, L.; Proto, M. C.; Laezza, C.; Mcguire, P. G.; Morbidelli, L.; Gazzerro, P.; Ziche, M.; Das, A.; Bifulco, M. | |
| Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells | 1-gen-2015 | Ciaglia, E.; Torelli, G.; Pisanti, S.; Picardi, P.; D'Alessandro, A.; Laezza, C.; Malfitano, A. M.; Fiore, D.; Pagano Zottola, A. C.; Proto, M. C.; Catapano, G.; Gazzerro, P.; Bifulco, M. | |
| Cannabinoids in the management of spasticity associated with multiple sclerosis | 1-gen-2008 | Malfitano, A. M.; Proto, M. C.; Bifulco, M. | |
| The first cosmetic treatise of history. A female point of view | 1-gen-2008 | Cavallo, P.; Proto, M. C.; Patruno, C.; Sorbo, A. D.; Bifulco, M. | |
| Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: Evidence for synergistic effects | 1-gen-2009 | Monteleone, P.; Bifulco, M.; Di Filippo, C.; Gazzerro, P.; Canestrelli, B.; Monteleone, F.; Proto, M. C.; Di Genio, M.; Grimaldi, C.; Maj, M. | |
| Pharmacological actions of statins: A critical appraisal in the management of cancer | 1-gen-2012 | Gazzerro, P.; Proto, M. C.; Gangemi, G.; Malfitano, A. M.; Ciaglia, E.; Pisanti, S.; Santoro, A.; Laezza, C.; Bifulco, M. | |
| Biological and pharmacological roles of N6-isopentenyladenosine: An emerging anticancer drug | 1-gen-2008 | Bifulco, M.; Malfitano, A. M.; Proto, M. C.; Santoro, A.; Caruso, M. G.; Laezza, C. | |
| The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase | 1-gen-2008 | Esposito, I.; Proto, M. C.; Gazzerro, P.; Laezza, C.; Miele, C.; Alberobello, A. T.; D'Esposito, V.; Beguinot, F.; Formisano, P.; Bifulco, M. | |
| Cannabidiol: State of the art and new challenges for therapeutic applications | 1-gen-2017 | Pisanti, S.; Malfitano, A. M.; Ciaglia, E.; Lamberti, A.; Ranieri, R.; Cuomo, G.; Abate, M.; Faggiana, G.; Proto, M. C.; Fiore, D.; Laezza, C.; Bifulco, M. | |
| Inhibition of 3-hydroxy-3-methylglutarylcoenzyme a reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells | 1-gen-2010 | Laezza, C.; Malfitano, A. M.; Proto, M. C.; Esposito, I.; Gazzerro, P.; Formisano, P.; Pisanti, S.; Santoro, A.; Caruso, M. G.; Bifulco, M. | |
| Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration | 1-gen-2015 | Pisanti, S.; Picardi, P.; Pallottini, V.; Martini, C.; Petrosino, S.; Proto, M. C.; Vitale, M.; Laezza, C.; Gazzerro, P.; Di Marzo, V.; Bifulco, M. | |
| Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth | 1-gen-2012 | Proto, M. C.; Gazzerro, P.; Di Croce, L.; Santoro, A.; Malfitano, A. M.; Pisanti, S.; Laezza, C.; Bifulco, M. | |
| Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells | 1-gen-2012 | Laezza, C.; D'Alessandro, A.; Paladino, S.; Malfitano, A. M.; Proto, M. C.; Gazzerro, P.; Pisanti, S.; Santoro, A.; Ciaglia, E.; Bifulco, M. | |
| N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux | 1-gen-2018 | Ranieri, R.; Ciaglia, E.; Amodio, G.; Picardi, P.; Proto, M. C.; Gazzerro, P.; Laezza, C.; Remondelli, P.; Bifulco, M.; Pisanti, S. | |
| Tetra-substituted pyrrole derivatives act as potent activators of p53 in melanoma cells | 1-gen-2019 | Proto, Maria Chiara; Fiore, Donatella; Forte, Giovanni; Cuozzo, Paola; Ramunno, Anna; Fattorusso, Caterina; Gazzerro, Patrizia; Pascale, Maria; Franceschelli, Silvia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15256
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20266932
- 2010 - 20195803
- 2000 - 20091966
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...223
- JOURNAL OF CLINICAL MEDICINE152
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS76
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY70
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19254
- Humans250
- Female133
- Male127
- SARS-CoV-2106
- inflammation103
- oxidative stress84
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10741
- ita2575
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15259